Percutaneous Coronary Intervention Is Not Superior to Optimal Medical Therapy in Chronic Coronary Syndrome: A

Ibadete Bytyçi1,2, Defrim Morina1, Sefer Bytyqi3

  • 1Clinic of Cardiology, University Clinical Centre of Kosovo, 10000 Prishtina, Kosovo.

Insights

Percutaneous coronary intervention (PCI) offers no long-term survival or symptomatic benefits for chronic coronary syndrome (CCS) patients over optimal medical therapy (OMT). Early quality of life improvements with PCI do not persist long-term.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Conflicting evidence exists on the benefits of percutaneous coronary intervention (PCI) versus optimal medical therapy (OMT) for chronic coronary syndrome (CCS).
  • Evaluating the comparative effectiveness of PCI and OMT on survival and symptom relief in CCS is crucial.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the short- and long-term clinical benefits of PCI compared to OMT in patients with CCS.
  • To assess the impact of PCI on major adverse cardiac events, mortality, myocardial infarction, revascularization, stroke, and quality of life.

Main Methods:

  • Meta-analysis of fifteen randomized controlled trials (RCTs) involving 16,443 patients with CCS.
  • Endpoints included major adverse cardiac events (MACEs), all-cause mortality, cardiovascular (CV) mortality, myocardial infarction (MI), urgent revascularization, stroke, and quality of life (QoL).
  • Evaluated clinical endpoints at very short (≤3 months), short- (<12 months), and long-term (≥ 12 months) follow-up.

Main Results:

  • At a mean follow-up of 27.7 months, PCI showed similar risks of MACE, all-cause mortality, CV mortality, and MI compared to OMT.
  • No significant differences were observed in stroke or hospitalizations for anginal symptoms between PCI and OMT groups.
  • PCI patients experienced improved QoL in the very short-term, but these benefits diminished by long-term follow-up.

Conclusions:

  • Percutaneous coronary intervention (PCI) does not provide significant long-term clinical benefit compared to optimal medical therapy (OMT) for patients with chronic coronary syndrome (CCS).
  • The findings suggest a need for careful patient selection for PCI, emphasizing that it does not improve long-term survival or reduce major adverse cardiac events.
  • While PCI may offer short-term quality of life improvements, these are not sustained, reinforcing the primary role of OMT in CCS management.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
20
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
13
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
16
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19